Cyclin A1 Methylation in Cervical Cancer
Author Information
Author(s): Kitkumthorn Nakarin, Yanatatsanajit Pattamawadee, Nuchjoe, Kiatpongsan Sorapop, Phokaew Chureerat, Triratanachat Surang, Trivijitsilp Prasert, Termrungruanglert Wichai, Tresukosol Damrong, Niruthisard Somchai, Mutirangura Apiwat
Primary Institution: Chulalongkorn University
Hypothesis
The study aims to evaluate the epigenetic status of cyclin A1 in human papillomavirus-associated cervical cancer.
Conclusion
Cyclin A1 promoter hypermethylation is common in cervical cancer and may serve as a potential tumor marker for early diagnosis of invasive cervical cancer.
Supporting Evidence
- Cyclin A1 methylation was found in 93.3% of invasive cervical cancers.
- No methylation was observed in normal cervical tissues or low-grade lesions.
- The study suggests that cyclin A1 methylation occurs earlier than morphological changes in cervical cancer.
Takeaway
This study found that a specific change in a gene called cyclin A1 is very common in cervical cancer, which could help doctors find this type of cancer earlier.
Methodology
The study used duplex methylation-specific PCR and reverse transcriptase PCR on cervical cancer cell lines and tissue samples.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website